San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Formula Is New CEO, New Home, Old Drug

BIOTECH: Investors See Good Bet in Heart Drug

San Diego’s abundance of intellectual capital and venture investors with deep pockets has lured yet another startup from its snow-steeped home to sunny Southern California.

3M Acquires Ivera Medical Corp. for Undisclosed Price

Ivera Medical Corp., a San Diego-based company that makes products that disinfect and protect devices used to access a patient’s bloodstream, is being purchased by 3M Co. of St. Paul, Minn.

Meritage Pharma Acquired by Drugmaker Shire for $70 Million

Dublin-based drugmaker Shire Plc has acquired San Diego-based Meritage Pharma for an upfront payment of $70 million, with another $175 million contingent on meeting milestones, according to a recent news release.

Tease photo

Chris Bernard Joins Epic Sciences as Chief Commercial Officer

Epic Sciences Inc., a San Diego-based diagnostics company, announced Wednesday the appointment of Chris Bernard as chief commercial officer.

Tandem Diabetes Care to Raise $60 Million in Underwritten Public Offering

Tandem Diabetes Care Inc., a medical device company and manufacturer of insulin pumps, announced in a statement Tuesday that it intends to raise $60 million in an underwritten public offering.

XIFIN Names James C. Malone Its New CFO

XIFIN Inc., a San Diego-based software and services company dedicated to optimizing the economics of health care, has named James C. Malone as its new chief financial officer.

Ligand Pharmaceuticals Reports 2014 Net Income of $12 Million

Ligand Pharmaceuticals Inc. reported net income of $12 million for the 2014 fiscal year, according to a recent regulatory filing.

Elcelyx Therapeutics Raises $5.8 Million in Financing

Elcelyx Therapeutics Inc., a biotechnology firm developing drugs for weight management and obesity-related metabolic disorders, has raised $5.8 million in a Series D financing round, according to a recent filing with the Securities and Exchange Commission.

Tease photo

AMN Healthcare Reports Q4 Net Income of $10 Million

The San Diego-based staffing company AMN Healthcare Services Inc. reported fourth-quarter net income of $10 million and net income per diluted share of $0.20. As a result, its stock increased nearly 14 percent to $22.96 per share.

Supreme Court Case Could Dismantle Health Care Law

Health Care Column

A looming Supreme Court case has put pressure on Congressional Republicans to design a new plan to replace President Obama’s signature health care law. But rather than develop new solutions, lawmakers seem to be producing more of the same. Out with the old, and… well, back in with the old.

Tease photo

Bastyr Fills Niche for Naturopathic Doctors

MEDICINE: Accredited School Is Seeing Increasing Enrollment

A new university in San Diego is training the next generation of primary care doctors in the state’s first and only accredited natural medicine school — Bastyr University.

Tease photo

OCTANe's CEO to Join UCSD Healthcare System

Matthew Jenusaitis will step down as president and chief executive officer of Aliso Viejo-based OCTANe to join the University of California San Diego Healthcare System.

Neurocrine Announces $225 Million Public Stock Offering

San Diego-based Neurocrine Biosciences Inc. has begun an underwritten public offering of shares of its common stock to raise aggregate proceeds of about $225 million.

Regen BioPharma Appoints Todd Caven CFO

Todd Caven has been appointed the new chief financial officer of Regen BioPharma Inc., a La Mesa-based biotechnology company focused on identifying undervalued regenerative medicine applications in the immunotherapy and stem cell space.

Bob Baltera Named CEO of Laguna Pharmaceuticals

La Jolla-based Laguna Pharmaceuticals, previously known as ChanRx, announced Tuesday the appointment of Bob Baltera as chief executive officer and the completion of a $30 million Series B financing.